Ibotta’s analyst story is shifting at the margins, with the price target trimmed from US$32 to US$29 while the fair value estimate edges to US$28.00 from US$27.86. Analysts are signaling a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results